Status:
WITHDRAWN
Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
Lead Sponsor:
University of California, San Diego
Conditions:
Transient Ischemic Attack
Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
Detailed Description
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
Eligibility Criteria
Inclusion
- Age 18 and older.
- Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent.
- Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period.
Exclusion
- Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents.
- Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis.
- Allergy to aspirin or clopidogrel.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00363753
Start Date
August 1 2006
End Date
March 1 2007
Last Update
August 2 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Hillcrest
San Diego, California, United States, 92103
2
UCSD
San Diego, California, United States, 92103